Form 4 Filing for Benjamin J. Hindson

Benjamin J. Hindson, a director and officer of 10x Genomics, Inc., reported a sale of 11,595 shares of Class A Common Stock on May 22, 2026. The shares were sold at a price of $24.4415 per share, totaling an undisclosed amount. This transaction was executed to cover tax withholding obligations associated with the vesting of restricted stock units. Following the sale, Mr. Hindson owns 502,000 shares of Class A Common Stock. The filing also notes that Mr. Hindson holds the title of President and Chief Scientific Officer.